Based on new discoveries in metabolic science, the investigational Revita™ duodenal mucosal resurfacing (DMR) procedure targets the upper intestine, or duodenum, with the aim of addressing a root cause of insulin resistance in type 2 diabetes.

WATCH THE VIDEO

Answer a few questions to see if you may qualify for the Revita™ T2D US clinical research study testing the investigational DMR procedure designed to elevate your body’s potential for better blood sugar control.

ANSWER QUESTIONS